Discover a new study that used extracellular volume measurement through spectral CT to quantify the proportion of ...

A new international study has found that over 15 million people across the US, UK, Germany, and France are unknowingly living ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

A novel blood-based test, HelioLiver Dx, has shown superior performance to traditional ultrasound in detecting early-stage hepatocellular carcinoma (HCC) among high-risk patients with liver cirrhosis, ...

Of note, the diagnosis of cirrhosis was performed using a combination of clinical evaluation, laboratory findings ... to assess liver stiffness. Surveillance esophagogastroduodenoscopy, abdominal ...

Traditional diagnostic approaches, including blood tests, imaging techniques such as ultrasound, MRI or CT scans ... 32 This is consistent with findings in cirrhosis and liver failure, where men are ...

Diagnosis: Radiology testing such as Computed Tomography (CT scan), Ultrasound, or Magnetic Resonance Imaging (MRI) is generally used for the diagnosis of liver cirrhosis. In some cases ...

Know the early signs of liver cirrhosis. 1. Fatigue and weakness: Persistent and unexplained fatigue is a common early complaint. This isn't the tiredness after a long day; it's a profound lack of ...

Understanding the specific amounts of alcohol that cause cirrhosis requires examining multiple factors that influence liver vulnerability. The journey from healthy liver tissue to scarred ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...

The company presented positive two-year results from the open-label compensated metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis arm of its phase 3 MAESTRO-NAFLD-1 trial at this ...